Study of S-1 Plus LV for Advanced Gastric Cancer

• Status: Completed
• Trial end date: 2014-03-01

Summary

The purpose of this study is to evaluate the effectiveness and safety of S-1 plus Leucovorin (1 week on and 1 week off) as first-line treatment for patients with metastatic and recurrent gastric cancer.

• Phase: Phase 2

Details

• Lead Sponsor: Sun Yat-sen University
• Collaborator: Taiho Pharmaceutical Co., Ltd.
• Treatments: Leucovorin; Tegafur